EUVIMEDEUVIMED entdecken
Crossref

Repurposing phenytoin as an anti-aggression drug: clinical evidence

Jan M. Keppel Hesselink

Neurological Disorders and Therapeutics · 2017

DOI: 10.15761/ndt.1000118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Disorders and Therapeutics, 2017. Verfasst von Jan M. Keppel Hesselink.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hesselink, J. M. K. (2017). Repurposing phenytoin as an anti-aggression drug: clinical evidence. Neurological Disorders and Therapeutics. https://doi.org/10.15761/ndt.1000118

Vancouver

Hesselink JMK. Repurposing phenytoin as an anti-aggression drug: clinical evidence. Neurological Disorders and Therapeutics. 2017. doi:10.15761/ndt.1000118

BibTeX
@article{Hesselink2017,
  author = {Hesselink, Jan M. Keppel},
  title = {Repurposing phenytoin as an anti-aggression drug: clinical evidence},
  journal = {Neurological Disorders and Therapeutics},
  year = {2017},
  doi = {10.15761/ndt.1000118}
}
Kostenlos starten →